230
Views
55
CrossRef citations to date
0
Altmetric
Original Research

Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer

, , , , , , , , , , ORCID Icon & show all
Pages 2323-2335 | Published online: 01 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Hongyu Liu, Yisheng Huang, Mingshu Huang, Zhijie Huang, Qin Wang, Ling Qing, Li Li, Shuaimei Xu & Bo Jia. (2022) Current Status, Opportunities, and Challenges of Exosomes in Oral Cancer Diagnosis and Treatment. International Journal of Nanomedicine 17, pages 2679-2705.
Read now
Ling Lu, Shikun Fang, Yue Zhang, Longtao Jin, Wenrong Xu & Zhaofeng Liang. (2021) Exosomes and Exosomal circRNAs: The Rising Stars in the Progression, Diagnosis and Prognosis of Gastric Cancer. Cancer Management and Research 13, pages 8121-8129.
Read now

Articles from other publishers (53)

Ali Hazrati, Zahra Mirsanei, Neda Heidari, Kosar Malekpour, Nasim Rahmani-Kukia, Ardeshir Abbasi & Sara Soudi. (2023) The potential application of encapsulated exosomes: A new approach to increase exosomes therapeutic efficacy. Biomedicine & Pharmacotherapy 162, pages 114615.
Crossref
Juan Bian, Nemal Gobalasingham, Anatolii Purchel & Jessica Lin. (2023) The Power of Field-Flow Fractionation in Characterization of Nanoparticles in Drug Delivery. Molecules 28:10, pages 4169.
Crossref
Daniela Lopes, Joana Lopes, Miguel Pereira-Silva, Diana Peixoto, Navid Rabiee, Francisco Veiga, Omid Moradi, Zhan-Hu Guo, Xiang-Dong Wang, João Conde, Pooyan Makvandi & Ana Cláudia Paiva-Santos. (2023) Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine. Military Medical Research 10:1.
Crossref
Swati Sharma, Rashmi Rana, Prem Prakash & Nirmal Kumar Ganguly. (2023) Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors. Molecular and Cellular Biochemistry.
Crossref
Weiping Zeng, Zhengbo Wen, Honglin Chen & Yuyou Duan. (2022) Exosomes as Carriers for Drug Delivery in Cancer Therapy. Pharmaceutical Research 40:4, pages 873-887.
Crossref
Terjahna Richards, Himaxi Patel, Ketan Patel & Frank Schanne. (2023) Endogenous Lipid Carriers—Bench-to-Bedside Roadblocks in Production and Drug Loading of Exosomes. Pharmaceuticals 16:3, pages 421.
Crossref
Xiao Liu, Qingdong Guo, Guangxun Gao, Zhengcong Cao, Zhihao Guan, Bo Jia, Weizhong Wang, Kuo Zhang, Wangqian Zhang, Shuning Wang, Weina Li, Qiang Hao, Yingqi Zhang, Meng Li, Wei Zhang & Jintao Gu. (2023) Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signaling. Journal of Nanobiotechnology 21:1.
Crossref
Fangyuan Xie, Yueying Huang, Yangyang Zhan & Leilei Bao. (2023) Exosomes as drug delivery system in gastrointestinal cancer. Frontiers in Oncology 12.
Crossref
Guixiu Xiao, Zihan Xu & Feng Luo. (2023) Combinational antitumor strategies of exosomes as drug carriers: Mini review. Frontiers in Pharmacology 13.
Crossref
Zhengchao Zhang, Lele Miao, Song Wang, Yang Zhao, Yongqiang Xie, Heng Yun, Zhijian Ren, Guan Wang, Muzhou Teng & Yumin Li. (2022) Study on the expression of c-Met in gastric cancer and its correlation with preoperative serum tumor markers and prognosis. World Journal of Surgical Oncology 20:1.
Crossref
Congcong Wang, Ning Li, Yutian Li, Shasha Hou, Wenxin Zhang, Zhaowei Meng, Shen Wang, Qiang Jia, Jian Tan, Renfei Wang & Ruiguo Zhang. (2022) Engineering a HEK-293T exosome-based delivery platform for efficient tumor-targeting chemotherapy/internal irradiation combination therapy. Journal of Nanobiotechnology 20:1.
Crossref
Qiurong Yang, Jing Xu, Jianmei Gu, Hui Shi, Jiayin Zhang, Jianye Zhang, Zhe‐Sheng Chen, Xinjian Fang, Taofeng Zhu & Xu Zhang. (2022) Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications. Advanced Science 9:34.
Crossref
Mohammad Azam Ansari, Muthu Thiruvengadam, Baskar Venkidasamy, Mohammad N. Alomary, Ahmad Salawi, Ill-Min Chung, Mohammad Ali Shariati & Maksim Rebezov. (2022) Exosome-based nanomedicine for cancer treatment by targeting inflammatory pathways: Current status and future perspectives. Seminars in Cancer Biology 86, pages 678-696.
Crossref
Yasunari Matsuzaka & Ryu Yashiro. (2022) Molecular Docking and Intracellular Translocation of Extracellular Vesicles for Efficient Drug Delivery. International Journal of Molecular Sciences 23:21, pages 12971.
Crossref
Qinhua Liu, Guanrong Dai, Yi Wu, Mingxia Zhang, Mingya Yang, Xiaonan Wang, Mingyue Song, Xiaodan Li, Ruixiang Xia & Zhengsheng Wu. (2022) iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma. Frontiers in Oncology 12.
Crossref
Xin-Chi Jiang, Tianyuan Zhang & Jian-Qing Gao. (2022) The in vivo fate and targeting engineering of crossover vesicle-based gene delivery system. Advanced Drug Delivery Reviews 187, pages 114324.
Crossref
Man Xiong, Mingsen Wang, Youhong Yan, Xiaowu Chen, Wanwei Guo, Ming Xu, Shaoyan Guo & Yeyang Wang. (2022) MACC1 Promotes the Progression and Is a Novel Biomarker for Predicting Immunotherapy Response in Colorectal Cancer. Journal of Oncology 2022, pages 1-17.
Crossref
Qian Xiao, Wei Zhao, Chentian Wu, Xuejiao Wang, Jianping Chen, Xiubo Shi, Suinan Sha, Jinheng Li, Xiaomei Liang, Yulu Yang, Haoyan Guo, Ying Wang & Jun‐Bing Fan. (2022) Lemon‐Derived Extracellular Vesicles Nanodrugs Enable to Efficiently Overcome Cancer Multidrug Resistance by Endocytosis‐Triggered Energy Dissipation and Energy Production Reduction. Advanced Science 9:20.
Crossref
Richa Gulati, Dhruva Nandi, Koustav Sarkar, P. Venkataraman, K. M. Ramkumar, Priya Ranjan & Rajiv Janardhanan. (2022) Exosomes as Theranostic Targets: Implications for the Clinical Prognosis of Aggressive Cancers. Frontiers in Molecular Biosciences 9.
Crossref
Ying Zhang, Qiqi Liu, Xinmeng Zhang, Haoqiang Huang, Shiqi Tang, Yujuan Chai, Zhourui Xu, Meirong Li, Xin Chen, Jia Liu & Chengbin Yang. (2022) Recent advances in exosome-mediated nucleic acid delivery for cancer therapy. Journal of Nanobiotechnology 20:1.
Crossref
Syed Nasir Abbas Bukhari. (2022) Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials. Pharmaceutics 14:4, pages 866.
Crossref
Débora Ferreira, João Nuno Moreira & Lígia R. Rodrigues. (2022) New advances in exosome-based targeted drug delivery systems. Critical Reviews in Oncology/Hematology 172, pages 103628.
Crossref
Tianyu Zhu, Zhihao Hu, Zhuoyin Wang, Hengxuan Ding, Ruixin Li, Jingtao Wang & Guojun Wang. (2022) microRNA-301b-3p from mesenchymal stem cells-derived extracellular vesicles inhibits TXNIP to promote multidrug resistance of gastric cancer cells. Cell Biology and Toxicology.
Crossref
Andrey Gorshkov, Lada Purvinsh, Alexandra Brodskaia & Andrey Vasin. (2022) Exosomes as Natural Nanocarriers for RNA-Based Therapy and Prophylaxis. Nanomaterials 12:3, pages 524.
Crossref
Lan Chen, Li Wang, Lingling Zhu, Zihan Xu, Yanyang Liu, Zhixi Li, Jin Zhou & Feng Luo. (2022) Exosomes as Drug Carriers in Anti-Cancer Therapy. Frontiers in Cell and Developmental Biology 10.
Crossref
Qirong Li, Dongxu Wang, Dayong Ding, Ye Feng, Ruizhi Hou, Dianfeng Liu, Chao Lin & Yongjian Gao. (2022) The Role and Application of Exosomes in Gastric and Colorectal Cancer. Frontiers in Pharmacology 12.
Crossref
Xiao-Cui Wei, Li-Juan Liu & Fan Zhu. (2022) Exosomes as potential diagnosis and treatment for liver cancer. World Journal of Gastrointestinal Oncology 14:1, pages 334-347.
Crossref
Xin Yang, Hai-Yang Liao & Hai-Hong Zhang. (2022) Roles of MET in human cancer. Clinica Chimica Acta 525, pages 69-83.
Crossref
Tania Limongi, Francesca Susa, Monica Marini, Marco Allione, Bruno Torre, Roberto Pisano & Enzo di Fabrizio. (2021) Lipid-Based Nanovesicular Drug Delivery Systems. Nanomaterials 11:12, pages 3391.
Crossref
Naoya Kuriyama, Yusuke Yoshioka, Shinsuke Kikuchi, Akihiko Okamura, Nobuyoshi Azuma & Takahiro Ochiya. (2021) Challenges for the Development of Extracellular Vesicle-Based Nucleic Acid Medicines. Cancers 13:23, pages 6137.
Crossref
Xiao Yu, Qingyuan Zheng, Qiyao Zhang, Shuijun Zhang, Yuting He & Wenzhi Guo. (2021) MCM3AP-AS1: An Indispensable Cancer-Related LncRNA. Frontiers in Cell and Developmental Biology 9.
Crossref
Yuying Zhu, He Zhang, Xingxing Han, Zhiyong Wang, Yanfen Cui, Ran Tian, Zhaosong Wang, Baoai Han, Jianfei Tian, Fei Zhang & Ruifang Niu. (2021) STAT3 mediated upregulation of C-MET signaling acts as a compensatory survival mechanism upon EGFR family inhibition in chemoresistant breast cancer cells. Cancer Letters 519, pages 328-342.
Crossref
Ying Zhang, Yu Xiao, Gaoge Sun, Xue Jin, Lerui Guo, Tian Li & Hang Yin. (2021) Harnessing the therapeutic potential of extracellular vesicles for cancer treatment. Seminars in Cancer Biology 74, pages 92-104.
Crossref
Migara Kavishka Jayasinghe, Melissa Tan, Boya Peng, Yuqi Yang, Gautam Sethi, Marco Pirisinu & Minh T.N. Le. (2021) New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies. Seminars in Cancer Biology 74, pages 62-78.
Crossref
Hanyu Zhang, Min Yang, Xu Wu, Qianxiu Li, Xin Li, Yueshui Zhao, Fukuan Du, Yu Chen, Zhigui Wu, Zhangang Xiao, Jing Shen, Qinglian Wen, Wei Hu, Chi Hin Cho, Meijuan Chen, Yejiang Zhou & Mingxing Li. (2021) The distinct roles of exosomes in tumor-stroma crosstalk within gastric tumor microenvironment. Pharmacological Research 171, pages 105785.
Crossref
Mingyuan Zou, Yue Du, Ruizhen Liu, Zeliang Zheng & Jian Xu. (2021) Nanocarrier‐delivered small interfering RNA for chemoresistant ovarian cancer therapy . WIREs RNA 12:5.
Crossref
Xiao-Huan Tang, Ting Guo, Xiang-Yu Gao, Xiao-Long Wu, Xiao-Fang Xing, Jia-Fu Ji & Zi-Yu Li. (2021) Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications. Molecular Cancer 20:1.
Crossref
Xin-Hui Cao, Ming-Xing Liang, Yang Wu, Kai Yang, Jin-Hai Tang & Wei Zhang. (2021) Extracellular vesicles as drug vectors for precise cancer treatment. Nanomedicine 16:17, pages 1519-1537.
Crossref
Ping Wang, Guang-Bin Sun, Guang-Xian Dou & Bai-Qing Wang. (2021) Long non‑coding RNA B3GALT5‑AS1 contributes to the progression of gastric cancer via interacting with CSNK2A1. Experimental and Therapeutic Medicine 22:3.
Crossref
Michaela Schulz-Siegmund & Achim Aigner. (2021) Nucleic acid delivery with extracellular vesicles. Advanced Drug Delivery Reviews 173, pages 89-111.
Crossref
Sepideh Mirzaei, Aliasghar Tabatabaei Mohammadi, Mohammad Hossein Gholami, Farid Hashemi, Ali Zarrabi, Amirhossein Zabolian, Kiavash Hushmandi, Pooyan Makvandi, Marek Samec, Alena Liskova, Peter Kubatka, Noushin Nabavi, Amir Reza Aref, Milad Ashrafizadeh, Haroon Khan & Masoud Najafi. (2021) Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance. Pharmacological Research 167, pages 105575.
Crossref
Milad Ashrafizadeh, Masoud Delfi, Farid Hashemi, Amirhossein Zabolian, Hossein Saleki, Morteza Bagherian, Negar Azami, Mahdi Vasheghani Farahani, Seyed Omid Sharifzadeh, Soodeh Hamzehlou, Kiavash Hushmandi, Pooyan Makvandi, Ali Zarrabi, Michael R. Hamblin & Rajender S. Varma. (2021) Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy. Carbohydrate Polymers 260, pages 117809.
Crossref
Sepideh Mirzaei, Kiavash Hushmandi, Amirhossein Zabolian, Hossein Saleki, Seyed Mohammad Reza Torabi, Adnan Ranjbar, SeyedHesam SeyedSaleh, Seyed Omid Sharifzadeh, Haroon Khan, Milad Ashrafizadeh, Ali Zarrabi & Kwang-seok Ahn. (2021) Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies. Molecules 26:8, pages 2382.
Crossref
Juan Sun, Xianze Wang, Zimu Zhang, Ziyang Zeng, Siwen Ouyang & Weiming Kang. (2021) The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer. Frontiers in Oncology 11.
Crossref
Mengyang Zhao, Nan Zhang, Ruigeng Yang, Deliang Chen & Yongxing Zhao. (2020) Which is Better for Nanomedicines: Nanocatalysts or Single‐Atom Catalysts?. Advanced Healthcare Materials 10:8.
Crossref
Lornella Seeneevassen, Emilie Bessède, Francis Mégraud, Philippe Lehours, Pierre Dubus & Christine Varon. (2021) Gastric Cancer: Advances in Carcinogenesis Research and New Therapeutic Strategies. International Journal of Molecular Sciences 22:7, pages 3418.
Crossref
Georgina E. Wood, Helen Hockings, Danielle M. Hilton & Stéphanie Kermorgant. (2021) The role of MET in chemotherapy resistance. Oncogene 40:11, pages 1927-1941.
Crossref
Fernanda G Kugeratski, Kathleen M McAndrews & Raghu Kalluri. (2021) Multifunctional Applications of Engineered Extracellular Vesicles in the Treatment of Cancer. Endocrinology 162:3.
Crossref
Dona Sinha, Sraddhya Roy, Priyanka Saha, Nabanita Chatterjee & Anupam Bishayee. (2021) Trends in Research on Exosomes in Cancer Progression and Anticancer Therapy. Cancers 13:2, pages 326.
Crossref
Alessia Brossa, Marta Tapparo, Valentina Fonsato, Elli Papadimitriou, Michela Delena, Giovanni Camussi & Benedetta Bussolati. (2021) Coincubation as miR-Loading Strategy to Improve the Anti-Tumor Effect of Stem Cell-Derived EVs. Pharmaceutics 13:1, pages 76.
Crossref
Guiping Zhao, Anni Zhou, Xiao Li, Shengtao Zhu, Yongjun Wang, Shutian Zhang & Peng Li. (2021) The Significance of Exosomal RNAs in the Development, Diagnosis, and Treatment of Gastric Cancer. Genes 12:1, pages 73.
Crossref
Dnyaneshwar Kalyane, Devendra Choudhary, Suryanarayana Polaka, Hanmant Goykar, Neelima Anup, Vishakha Tambe, Kiran Kalia & Rakesh K. Tekade. (2020) Exosomes in multidrug-resistant cancer. Current Opinion in Pharmacology 54, pages 109-120.
Crossref
Xu Lu, Yu Zhang, Guangfei Xie, Ye Ding, Hui Cong & Shihai Xuan. (2020) Exosomal non‑coding RNAs: Novel biomarkers with emerging clinical applications in gastric cancer (Review). Molecular Medicine Reports.
Crossref